bims:reports

Here are our 86 reports, sorted by timeliness.

bims-malgli
Biology of malignant gliomas, Oltea Sampetrean, Keio University, since 2020‒06‒14
bims-metlip
Methods and protocols in metabolomics and lipidomics, Sofia Costa, Matterworks, since 2019‒10‒13
bims-moremu
Molecular regulators of muscle mass, Anna Vainshtein, Craft Science Inc., since 2021‒02‒14
bims-camemi
Mitochondrial metabolism in cancer, Christian Frezza, University Hospital Cologne, since 2018‒08‒19
bims-imseme
Immunosenescence and T cell metabolism, Pierpaolo Ginefra, Ludwig Institute for Cancer Research, since 2020‒07‒12
bims-mitmed
Mitochondrial medicine, Dario Brunetti, Fondazione IRCCS Istituto Neurologico, since 2021‒10‒17
bims-mascan
Mass spectrometry in cancer research, Giovanny Rodriguez Blanco, University of Edinburgh, since 2019‒04‒28
bims-mitdis
Mitochondrial disorders, Catalina Vasilescu, University of Helsinki, since 2021‒01‒24
bims-proteo
Proteostasis, Eric Chevet, INSERM, since 2020‒04‒26
bims-tremyl
Therapy resistance biology in myeloid leukemia, Paolo Gallipoli, Barts Cancer Institute, Queen Mary University of London, since 2020‒06‒21
bims-auttor
Autophagy and mTOR, Viktor Korolchuk, Newcastle University, since 2019‒02‒17
bims-exocan
Exosomes roles in cancer, Muhammad Rizwan, COMSATS University, since 2022‒07‒31
bims-senagi
Senescence and aging, Maria Grazia Vizioli, Mayo Clinic, since 2020‒09‒06
bims-resufa
Respiratory supercomplex factors, Vera Strogolova, Strong Microbials, Inc, since 2018‒03‒11
bims-ershed
ER Stress in Health and Diseases, Matías Eduardo González Quiroz, Worker’s Hospital, since 2021‒02‒28
bims-unfpre
Unfolded protein response, Susan Logue, University of Manitoba, since 2018‒12‒23
bims-mricoa
MRI contrast agents, Merve Yavuz, Bilkent University, since 2021‒07‒11
bims-ectoca
Epigenetic control of tolerance in cancer, Ankita Daiya, BITS Pilani, since 2021‒06‒27
bims-mepmim
Metabolites in pathological microenvironments and immunometabolism, Erika Mariana Palmieri, NIH/NCI Laboratory of Cancer ImmunoMetabolism, since 2022‒03‒13
bims-mimbat
Mitochondrial metabolism in brown adipose tissue, José Carlos de Lima-Júnior, University of California San Francisco, since 2022‒02‒20
bims-istrec
Integrated stress response in cancer, the Vincenzo Ciminale lab, Istituto Oncologico Veneto, since 2021‒09‒05
bims-mibica
Mitochondrial bioenergetics in cancer, Kelsey Fisher-Wellman, East Carolina University, since 2020‒02‒23
bims-traimu
Trained immunity, Yantong Wan, Southern Medical University, since 2022‒05‒29
bims-librar
Biomedical librarianship, Thomas Krichel, Open Library Society, since 2017‒10‒29
bims-myxlip
Myxoid liposarcoma, Laura Mannarino, Humanitas Research, since 2020‒12‒06
bims-mesote
Mesothelioma, Laura Mannarino, Humanitas Research, since 2021‒01‒17
bims-mecosi
Membrane contact sites, Verena Kohler, University of Graz, since 2021‒06‒13
bims-nocaut
Non-canonical autophagy, Quentin Frenger, University of Strasbourg, since 2022‒07‒17
bims-nucpor
Nuclear pore complex and nucleoporins in stress, aging and disease, Sara Mingu, Johannes Gutenberg University, since 2021‒04‒25
bims-indpro
Intrinsically disordered proteins, Sara Mingu, Johannes Gutenberg University, since 2022‒01‒30
bims-cagime
Cancer, aging and metabolism, Kıvanç Görgülü, Technical University of Munich, since 2020‒05‒03
bims-bicyki
Bicaudal-C1 and interactors in cystic kidney disease, Céline Gagnieux, École Polytechnique Fédérale de Lausanne (EPFL), since 2020‒10‒25
bims-pimaco
PI3K and MAPK signalling in colorectal cancer, Lucas B. Zeiger, Beatson Institute for Cancer Research, since 2020‒10‒18
bims-madeba
Mal de débarquement syndrome, Jun Maruta, Mount Sinai Health System, since 2018‒08‒12
bims-climfi
Cerebellar cortical circuitry, Jun Maruta, Mount Sinai Health System, since 2017‒12‒24
bims-lypmec
Lysosomal positioning and metabolism in cardiomyocytes, Satoru Kobayashi, New York Institute of Technology, since 2022‒08‒21
bims-kimdis
Ketones, inflammation and mitochondria in disease, Matías Javier Monsalves Álvarez , Universidad de O’Higgins, since 2022‒07‒31
bims-nimamd
Neuroimmunity and neuroinflammation in ageing and metabolic disease, Fawaz Alzaïd, Sorbonne Université, since 2021‒11‒21
bims-hafaim
Heart failure metabolism, Kyle McCommis, Saint Louis University, since 2021‒02‒21
bims-proarb
Proteostasis in aging and regenerative biology, Rich Giadone, Harvard University, since 2021‒05‒16
bims-tumhet
Tumor Heterogeneity, Sergio Marchini, Humanitas Research, since 2021‒05‒16
bims-almceb
Acute Leukemia Metabolism and Cell Biology, Camila Kehl Dias, Federal University of Rio Grande do Sul, since 2021‒01‒03
bims-netuvo
Nerves in tumours of visceral organs, Maksym V. Kopanitsa, The Francis Crick Institute, since 2021‒09‒19
bims-nenemi
Neuroinflammation, neurodegeneration and mitochondria, Marco Tigano, Thomas Jefferson University, since 2021‒09‒19
bims-mecami
Metabolic interactions between cancer cells and their microenvironment, Linda Chan, Yale University, since 2022‒09‒18
bims-skolko
Scholarly communication, Thomas Krichel, Open Library Society, since 2018‒12‒30
bims-mitdyn
Mitochondrial dynamics: mechanisms, Edmond Chan, Queen’s University, School of Medicine, since 2020‒07‒12
bims-ciryme
Circadian rhythms and metabolism, Gabriela Da Silva Xavier, University of Birmingham, since 2019‒02‒03
bims-tricox
Translation, ribosomes and COX, Yash Verma, University of Delhi South Campus, since 2022‒06‒19
bims-mitran
Mitochondrial Translation, Andreas Aufschnaiter, University of Graz, since 2021‒05‒16
bims-imicid
Immunometabolism of infection, cancer and immune-mediated disease, Dylan Ryan, University of Cambridge, since 2021‒09‒26
bims-mosdis
Mosquito distribution and disease, Richard Halfpenny, Staffordshire University, since 2020‒02‒09
bims-supasi
Sulfation pathways and signalling, Jonathan Wolf Mueller, University of Birmingham, since 2022‒01‒02

bims-micpro
Discovery and characterization of microproteins, Thomas Farid Martínez, University of California, Irvine, since 2020‒05‒10
bims-toxgon
Toxoplasma gondii metabolism, Lakesh Kumar, BITS Pilani, since 2022‒08‒07
bims-tucedo
Tumor cell dormancy, Isabel Puig Borreil, Vall d’Hebron Institute of Oncology, since 2020‒03‒01
bims-instec
Intestinal stem cells and chemoresistance in colon cancer and intestinal regeneration, Maria-Virginia Giolito, Free University of Brussels, since 2021‒07‒25
bims-lysosi
Lysosomes and signaling, Stephanie Fernandes, Max Planck Institute for Biology of Ageing, since 2020‒06‒28
bims-mikwok
Mitochondrial quality control, Avinash N. Mukkala, University of Toronto, since 2020‒08‒16
bims-glucam
Glutamine cancer metabolism, Sreeparna Banerjee, Middle East Technical University, since 2020‒09‒06
bims-pideca
Class IA PI3K signalling in development and cancer, Ralitsa Radostinova Madsen, University College London Cancer Institute, since 2019‒08‒04
bims-mideyd
Mitochondrial dysfunction in eye diseases, Sachin Gahg, Indiana University Bloomington, since 2021‒11‒28
bims-mitper
Mitochondrial Permeabilization, Bradley Irizarry, Thomas Jefferson University, since 2022‒09‒11
bims-drudre
Targeted drug delivery and programmed release mechanisms, Ceren Kimna, Technical University of Munich, since 2021‒01‒10
bims-apauto
Apoptosis and autophagy, Su Hyun Lee, Seoul National University, since 2021‒02‒07
bims-cadres
Cancer drug resistance, Rana Gbyli, Yale University, since 2022‒07‒24
bims-plasge
Plastid genes, Vera S. Bogdanova, Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, since 2018‒04‒29
bims-novged
Non-viral vectors for gene delivery, the Merkel lab, Ludwig-Maximilians University, since 2021‒05‒02
bims-limsir
Lipophilic modified siRNAs, Ivan V. Chernikov, Institute of Сhemical Biology and Fundamental Medicine of the SB RAS, since 2022‒05‒29

bims-medebr
Metabolism of the developing brain, Regina F. Fernández, Johns Hopkins University, since 2021‒11‒14
bims-meprid
Metabolic-dependent epigenetic reprogramming in differentiation and disease, Alessandro Carrer, Veneto Institute of Molecular Medicine, since 2020‒08‒30
bims-paceca
Patient-centred care, Rob Penfold, Queensland Health, since 2022‒04‒03
bims-evares
Evaluation of research, Thomas Krichel, Open Library Society, since 2019‒01‒06
bims-ovdlit
Ovarian cancer: early diagnosis, liquid biopsy and therapy, Lara Paracchini, Humanitas Research, since 2021‒03‒07

bims-crepig
Chromatin regulation and epigenetics in cell fate and cancer, Connor Rogerson, University of Cambridge, since 2020‒03‒22
bims-glecem
Glycogen metabolism in exercise, cancer and energy metabolism, Dipsikha Biswas, University of Copenhagen, since 2022‒01‒23
bims-cytox1
Cytochrome oxidase subunit 1, Gavin McStay, Liverpool John Moores University, since 2017‒02‒05
bims-stacyt
Metabolism and the paracrine crosstalk between cancer and the organism, Cristina Muñoz Pinedo, L’Institut d’Investigació Biomèdica de Bellvitge, since 2017‒12‒24
bims-orenst
Organs-on-chips and engineered stem cell models, Joram Mooiweer, University of Groningen, since 2020‒12‒06

bims-noxint
NADPH oxidases in tumorigenesis, Laia Caja Puigsubira, Uppsala University, since 2019‒03‒24
bims-catcri
CAR-T cells, CRISPR and cancer, Lisa Dwane, AstraZeneca, since 2022‒07‒31
bims-meluca
Metabolism of non-small cell lung carcinoma, the Muñoz-Pinedo/Nadal (PReTT) lab, L’Institut d’Investigació Biomèdica de Bellvitge, since 2018‒07‒22
bims-lymeca
Lysosome metabolism in cancer, Harilaos Filippakis, University of New England, since 2022‒01‒02

bims-cabrim
Cancer-brain interactions: molecular mechanisms, Bojana Milutinovic, MD Anderson Cancer Center, since 2022‒07‒31

bims-tubesc
Molecular mechanisms in tuberous sclerosis, Marti Cadena Sandoval, Columbia University, since 2021‒01‒17
bims-lifras
Li-Fraumeni syndrome, Joanna Zawacka-Pankau, Karolinska Institutet, since 2019‒08‒11

The list above does not contain the lagging reports.